IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative to Consumer Staples Sector Median (N=180)
Metric
CTVA
Benchmark
P/E Ratio
50.6x
+53%
EV/EBITDA
36.1x
+422%
Price / Book
2.4x
Implied Value Audit
OVERVALUED
Implied Fair Value (vs Sector)
-64.0%
$30.05Spot: $83.56
Spot
Implied
-50% Delta+50% Delta
Relative valuation derived from Consumer Staples sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 48.5GRADE C
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
4.7%
Sector: 7.7%
Dividend Analysis audit
GROWTH
1.02%
Trailing Yield
$1.02
Per $100 Invested
Modest dividend — capital prioritized for reinvestment.
Est. Payout Ratio
52%SAFE
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, Corteva, Inc. (CTVA) receives a "Hold" rating with a composite score of 51.7/100, ranked #209 out of 4446 stocks. Key factor scores: Quality 49/100, Value 51/100, Momentum 60/100. This is quantitative analysis only — not investment advice.
Corteva, Inc. (CTVA) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does Corteva, Inc. Do?
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. Corteva, Inc. (CTVA) is classified as a large-cap stock in the Consumer Staples sector, specifically within the Agriculture industry. The company is led by CEO Charles V. Magro and employs approximately 21,000 people. With a market capitalization of $56.3B, CTVA is one of the prominent companies in the Consumer Staples sector.
Corteva, Inc. (CTVA) Stock Rating — Hold (April 2026)
As of April 2026, Corteva, Inc. receives a Hold rating with a composite score of 51.7/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.CTVA ranks #209 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, Corteva, Inc. ranks #9 of 180 stocks, placing it in the top 10% of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
CTVA Stock Price and 52-Week Range
Corteva, Inc. (CTVA) currently trades at $83.56. The 52-week high for CTVA is $80.69, which means the stock is currently trading 3.6% from its annual peak. The 52-week low is $53.40, putting the stock 56.5% above its annual trough. Recent trading volume was 0 shares, suggesting relatively thin trading activity.
Is CTVA Overvalued or Undervalued? — Valuation Analysis
Corteva, Inc. (CTVA) carries a value factor score of 51/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 50.56x, compared to the Consumer Staples sector average of 33.11x — a premium of 53%. The price-to-book ratio stands at 2.35x, versus the sector average of 1.74x. The price-to-sales ratio is 3.62x, compared to 0.35x for the average Consumer Staples stock. On an enterprise value basis, CTVA trades at 36.14x EV/EBITDA, versus 6.93x for the sector.
Overall, CTVA's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
Corteva, Inc. Profitability — ROE, Margins, and Quality Score
Corteva, Inc. (CTVA) earns a quality factor score of 49/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is 4.7%, compared to the Consumer Staples sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 2.6% versus the sector average of 3.1%.
On a margin basis, Corteva, Inc. reports gross margins of 42.9%, compared to 26.2% for the sector. The operating margin is 1.1% (sector: 2.9%). Net profit margin stands at 0.2%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at -57.2% on a trailing basis, compared to 3.1% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
CTVA Debt, Balance Sheet, and Financial Health
Corteva, Inc. has a debt-to-equity ratio of 76.0%, compared to the Consumer Staples sector average of 72.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 1.43x, suggesting adequate working capital coverage. Total debt on the balance sheet is $4.37B. Cash and equivalents stand at $2.51B.
CTVA has a beta of 0.58, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for Corteva, Inc. is 84/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.
Corteva, Inc. Revenue and Earnings History — Quarterly Trend
In TTM 2026, Corteva, Inc. reported revenue of $15.82B and earnings per share (EPS) of $1.60. Net income for the quarter was $1.13B. Gross margin was 42.9%. Operating income came in at $1.58B.
In FY 2025, Corteva, Inc. reported revenue of $17.40B and earnings per share (EPS) of $1.60. Net income for the quarter was $1.10B. Gross margin was 47.3%. Revenue grew 2.9% year-over-year compared to FY 2024. Operating income came in at $1.69B.
In Q3 2025, Corteva, Inc. reported revenue of $2.62B and earnings per share (EPS) of $-0.47. Net income for the quarter was $-318M. Gross margin was 37.2%. Revenue grew 12.6% year-over-year compared to Q3 2024. Operating income came in at $-370M.
In Q2 2025, Corteva, Inc. reported revenue of $6.46B and earnings per share (EPS) of $1.92. Net income for the quarter was $1.32B. Gross margin was 54.6%. Revenue grew 5.6% year-over-year compared to Q2 2024. Operating income came in at $1.80B.
Over the past 8 quarters, Corteva, Inc. has demonstrated a growth trajectory, with revenue expanding from $6.11B to $15.82B. Investors analyzing CTVA stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
CTVA Dividend Yield and Income Analysis
Corteva, Inc. (CTVA) currently pays a dividend yield of 1.0%. At this yield, a $10,000 investment in CTVA stock would generate approximately $$102.00 in annual dividend income. This compares to the Consumer Staples sector average dividend yield of 0.4%, meaning CTVA offers above-average income for its sector.
CTVA Momentum and Technical Analysis Profile
Corteva, Inc. (CTVA) has a momentum factor score of 60/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 39/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 21/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
CTVA vs Competitors — Consumer Staples Sector Ranking and Peer Comparison
Comparing CTVA against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full CTVA vs S&P 500 (SPY) comparison to assess how Corteva, Inc. stacks up against the broader market across all factor dimensions.
CTVA Next Earnings Date
No upcoming earnings date has been announced for Corteva, Inc. (CTVA) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy CTVA? — Investment Thesis Summary
Corteva, Inc. presents a balanced picture with arguments on both sides. Price momentum is positive at 60/100, suggesting the trend favors buyers. Low volatility (stability score 84/100) reduces downside risk.
In summary, Corteva, Inc. (CTVA) earns a Hold rating with a composite score of 51.7/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on CTVA stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
Corteva, Inc. (CTVA) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
Corteva, Inc. is currently rated as a Hold, a reflection of its mixed financial performance and valuation. While the company boasts a strong gross margin and operates in a relatively stable sector, concerns arise from its high P/E ratio compared to the sector, negative revenue growth, and inconsistent profitability. The company's strategic focus on innovation and digital solutions offers potential for future growth, but current financial metrics suggest a need for improved operational efficiency and profitability to justify a more optimistic rating.
The Hold rating is further supported by the company's relatively weak returns on equity compared to its peers, coupled with a high debt-to-equity ratio. Although Corteva possesses a narrow economic moat due to its proprietary seed technologies and crop protection products, the current valuation does not fully reflect the risks associated with fluctuating commodity prices, regulatory changes, and intense competition within the agricultural sector. Therefore, while Corteva holds promise, a cautious approach is warranted until the company demonstrates sustained improvements in profitability and revenue growth.
Business Strategy & Overview
Corteva operates as a major player in the global agriculture industry, focusing on two primary segments: Seed and Crop Protection. The Seed segment is dedicated to developing and supplying advanced germplasm and traits designed to optimize crop yields. This includes trait technologies that enhance resistance to environmental stressors, diseases, insects, and herbicides, as well as improving food and nutritional characteristics. The company also offers digital solutions aimed at assisting farmers in making informed decisions to maximize product selection, yield, and profitability. This integrated approach, combining physical products with digital tools, is central to Corteva's strategy of providing comprehensive solutions to farmers.
The Crop Protection segment focuses on providing products that protect crops from weeds, insects, pests, and diseases. This includes herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. Corteva's strategy in this segment involves developing and marketing innovative crop protection products that enhance crop health both above and below ground. The company invests heavily in research and development to create new and improved products that address the evolving needs of farmers and the challenges posed by changing environmental conditions and pest pressures.
Corteva's strategic positioning involves leveraging its strong research and development capabilities to create differentiated products and solutions that offer superior value to farmers. The company focuses on developing proprietary technologies and traits that provide a competitive advantage in the market. This includes investing in gene editing technologies and other advanced breeding techniques to develop crops with improved yields, disease resistance, and other desirable traits. Corteva also emphasizes sustainability in its product development and business practices, aiming to reduce the environmental impact of agriculture and promote sustainable farming practices.
The company's product pipeline includes a range of new seed varieties and crop protection products that are currently in development or undergoing regulatory approval. These products are designed to address specific needs in different geographic regions and crop types. Corteva's digital solutions are also an important part of its product pipeline, with ongoing development of new tools and platforms that provide farmers with real-time data and insights to optimize their farming operations. The company's strategic focus on innovation and digital solutions is aimed at driving future growth and enhancing its competitive position in the agriculture industry.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
-57.2%
Sector: 3.1%
-1918% VS SCTR
Economic Moat Analysis
Corteva possesses a narrow economic moat, primarily derived from its intangible assets and, to a lesser extent, switching costs. The company's significant investment in research and development has resulted in a portfolio of proprietary seed technologies and crop protection products that are protected by patents and trade secrets. These intangible assets provide Corteva with a competitive advantage by allowing it to offer differentiated products that deliver superior value to farmers. The development of new seed varieties and crop protection products requires significant time, expertise, and capital, creating a barrier to entry for potential competitors.
The strength of Corteva's moat is somewhat limited by the nature of the agriculture industry. While the company's proprietary technologies provide a competitive edge, farmers often have multiple options for seed and crop protection products. The availability of generic alternatives and the potential for new innovations from competitors can erode Corteva's market share and pricing power. Furthermore, the agriculture industry is subject to regulatory changes and environmental factors that can impact the demand for specific products and technologies.
Switching costs for farmers can also contribute to Corteva's narrow moat. Farmers often develop relationships with specific suppliers and become familiar with their products and services. Switching to a new supplier can involve learning new techniques, adjusting farming practices, and potentially facing uncertainty about the performance of new products. However, these switching costs are not always significant, as farmers are often willing to try new products if they offer a clear improvement in yield, cost, or performance.
Corteva's moat is not considered wide because the agriculture industry is characterized by intense competition and evolving technologies. While the company has a strong position in certain segments of the market, it faces challenges from both large multinational corporations and smaller, more specialized companies. The rapid pace of innovation in areas such as gene editing and digital agriculture means that Corteva must continuously invest in research and development to maintain its competitive advantage. The company's ability to successfully commercialize new technologies and adapt to changing market conditions will be crucial in determining the long-term strength of its economic moat.
Financial Health & Profitability
Corteva's financial health presents a mixed picture. The company's revenue for FY2025 was $17.40 billion, with a net income of $1.10 billion, translating to an EPS of $1.60. However, the revenue figure represents a significant decline of -57.2% compared to the sector average of 4.3%. This is a concerning trend that needs to be addressed. The gross margin of 47.3% is robust, significantly higher than the sector average of 26.0%, indicating strong pricing power and efficient cost management in its core operations. However, the operating margin of 9.7% is lower than the gross margin, suggesting that operating expenses are consuming a substantial portion of the gross profit.
Examining the quarterly financial history reveals some volatility. While Q2 FY2025 showed a strong performance with a revenue of $6.46 billion and a net income of $1.32 billion, Q3 FY2025 reported a net loss of $318 million on revenue of $2.62 billion. This inconsistency raises concerns about the company's ability to maintain consistent profitability throughout the year. The operating margin also fluctuated significantly, ranging from -14.1% in Q3 FY2025 to 27.9% in Q2 FY2025, indicating potential issues with cost control or seasonal variations in demand.
Corteva's balance sheet shows a total cash position of $2.51 billion and total debt of $4.37 billion, resulting in a debt-to-equity ratio of 76.00, slightly higher than the sector average of 70.50. While the current ratio of 1.43 indicates sufficient liquidity to meet short-term obligations, the high level of debt could constrain the company's ability to invest in future growth opportunities or weather economic downturns. The free cash flow of $756.30 million is positive but relatively low compared to the company's market capitalization, suggesting that Corteva may need to improve its cash flow generation to support future investments and shareholder returns.
Corteva's return on equity (ROE) of 4.7% is significantly lower than the sector average of 7.8%, indicating that the company is not generating as much profit from shareholders' equity as its peers. This could be due to a combination of factors, including lower net margins, higher leverage, or inefficient asset utilization. Improving ROE should be a key priority for Corteva's management team. Overall, Corteva's financial health is characterized by strong gross margins but inconsistent profitability, high debt levels, and relatively low returns on equity. The company needs to address these challenges to improve its financial performance and create long-term value for shareholders.
Valuation Assessment
Corteva's valuation presents a mixed picture. The company's P/E ratio of 48.3x is significantly higher than the consumer staples sector average of 34.2x, suggesting that the stock is relatively expensive compared to its peers. This premium valuation may be justified if investors expect Corteva to deliver strong earnings growth in the future. However, given the company's recent revenue decline and inconsistent profitability, the high P/E ratio raises concerns about whether the stock is overvalued.
The EV/EBITDA ratio of 7.7x is slightly higher than the sector average of 7.3x, indicating that the company is fairly valued on an enterprise value basis. However, EBITDA can be influenced by accounting choices and may not fully reflect the company's underlying cash flow generation. The free cash flow yield, which is not explicitly provided but can be estimated based on the market cap and free cash flow, is relatively low, suggesting that the stock is not particularly attractive from a cash flow perspective.
Considering Corteva's historical financial performance, the current valuation appears to be somewhat optimistic. The company's revenue growth has been inconsistent, and its profitability has fluctuated significantly. While Corteva has a strong position in the agriculture industry and a portfolio of proprietary technologies, the company faces challenges from competition, regulatory changes, and fluctuating commodity prices. These factors suggest that the stock may not be worth a significant premium to its peers.
Overall, Corteva's valuation appears to be fair to slightly expensive, given its current financial performance and the risks associated with its business. The high P/E ratio suggests that investors are expecting strong earnings growth, but the company's recent revenue decline and inconsistent profitability raise concerns about whether these expectations are realistic. A more attractive entry point may be warranted if the company can demonstrate sustained improvements in its financial performance and address the challenges facing its business.
Risk & Uncertainty
Corteva faces several specific risks that could impact its financial performance and valuation. One significant risk is the volatility of commodity prices. The prices of agricultural commodities such as corn, soybeans, and wheat can fluctuate significantly due to factors such as weather conditions, global supply and demand, and government policies. These fluctuations can impact the demand for Corteva's products and services, as well as the profitability of its customers. A decline in commodity prices could lead to lower sales volumes and reduced pricing power for Corteva.
Regulatory risks also pose a significant threat to Corteva's business. The agriculture industry is subject to extensive regulation related to the use of pesticides, genetically modified organisms (GMOs), and other agricultural inputs. Changes in these regulations could restrict the use of certain products, increase compliance costs, or delay the approval of new technologies. For example, stricter regulations on the use of neonicotinoid insecticides could impact the demand for Corteva's insecticide products. Furthermore, international trade policies and tariffs can also impact Corteva's ability to access global markets and compete effectively.
Competition is another major risk factor for Corteva. The agriculture industry is highly competitive, with numerous large multinational corporations and smaller, more specialized companies vying for market share. Corteva faces competition from companies such as Bayer, Syngenta, and BASF, as well as from generic seed and crop protection product manufacturers. The development of new technologies and the introduction of generic alternatives can erode Corteva's market share and pricing power. The company must continuously invest in research and development to maintain its competitive advantage and develop innovative products that meet the evolving needs of farmers.
Finally, Corteva faces risks related to its debt levels. The company has a significant amount of debt on its balance sheet, which could constrain its ability to invest in future growth opportunities or weather economic downturns. High debt levels can also increase the company's vulnerability to rising interest rates. Corteva must carefully manage its debt levels and maintain sufficient liquidity to meet its financial obligations.
Bulls Say / Bears Say
The Bull Case
BULL VIEWCorteva's focus on innovative seed technologies and crop protection products will drive long-term growth and profitability as farmers seek higher yields and more sustainable solutions.
BULL VIEWThe company's strong gross margins and cost-cutting initiatives will lead to improved operating margins and increased free cash flow generation, supporting a higher valuation.
BULL VIEWCorteva's digital agriculture platform will provide farmers with valuable insights and decision-making tools, creating a sticky customer base and driving recurring revenue streams.
The Bear Case
BEAR VIEWCorteva's high P/E ratio and inconsistent profitability make the stock overvalued, especially given the risks associated with commodity price volatility and regulatory changes.
BEAR VIEWThe company's high debt levels and relatively low return on equity limit its financial flexibility and ability to invest in future growth opportunities.
BEAR VIEWIntense competition in the agriculture industry and the potential for generic alternatives will erode Corteva's market share and pricing power, hindering its ability to achieve sustainable growth.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score CTVA and 4,400+ other equities.
Corteva, Inc. exhibits a 357% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
2.6%
Sector: 3.1%
Gross Margin
Pricing power and cost efficiency
42.9%
Sector: 26.2%
Operating Margin
Core business profitability
1.1%
Sector: 2.9%
Net Margin
Bottom-line profitability
0.2%
Sector: 1.6%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
Sector Avg Yield0.38%
Yield Delta+168%
Income Projection audit
A $10,000 investment would generate approximately $102 annually in dividends at the current trailing rate.
